AVAH — Aveanna Healthcare Holdings Share Price
- $891.58m
- $2.26bn
- $2.02bn
- 57
- 74
- 88
- 86
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 32.67 | ||
PEG Ratio (f) | 0.44 | ||
EPS Growth (f) | 286.8% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 33.88 | ||
Price to Sales | 0.44 | ||
EV to EBITDA | 13.23 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 11.08% | ||
Return on Equity | n/a | ||
Operating Margin | 6.9% |
Financial Summary
Year End 28th Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1,495.11 | 1,678.62 | 1,787.64 | 1,895.21 | 2,024.51 | 2,115.76 | 2,221.36 | 7.9% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +50.83 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Aveanna Healthcare Holdings Inc. is a provider of diversified home care platform. The Company provides a range of specialized care to address the complex needs of each patient it serves across the full range of patient populations: newborns, children, adults and seniors. It has three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment provides home health, hospice and specialty program services to predominately elderly populations seeking compassionate care and assistance with activities of daily living in the home. Medical Solutions segment provides needed supplies to patients requiring enteral nutrition services or respiratory care. Enteral nutrition (tube or intravenous (IV)) feeding, is a way of delivering nutrition directly to the stomach or small intestine on an as-needed basis.
Directors
- Rodney Windley CHM (68)
- Tony Strange CEO (58)
- David Afshar CFO (49)
- Jeff Shaner COO (48)
- Ed Reisz CAD (62)
- Patrick Cunningham CCO (65)
- Shannon Drake GCN (46)
- Beth Rubio OTH (64)
- Victor Ganzi IND (74)
- Chris Gordon IND (46)
- Devin Oreilly IND (46)
- Sheldon Retchin IND (63)
- Steven Rodgers IND (49)
- Robert Williams IND (56)
- Richard Zoretic IND (62)
- Last Annual
- December 28th, 2024
- Last Interim
- December 28th, 2024
- Incorporated
- November 30th, 2016
- Public Since
- April 29th, 2021
- No. of Shareholders
- 9,000
- No. of Employees
- 3,500
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 195,093,866

- Address
- 400 Interstate North Parkway, Ste 1700, ATLANTA, 30339
- Web
- https://ir.aveanna.com/
- Phone
- +1 7704411580
- Contact
- Matthew Buckhalter
- Auditors
- Ernst & Young LLP
Upcoming Events for AVAH
Q1 2025 Aveanna Healthcare Holdings Inc Earnings Call
Aveanna Healthcare Holdings Inc Annual Shareholders Meeting
Aveanna Healthcare Holdings Inc at Bank of America Global Healthcare Conference
Aveanna Healthcare Holdings Inc Annual Shareholders Meeting
Q2 2025 Aveanna Healthcare Holdings Inc Earnings Release
Similar to AVAH
Acadia Healthcare
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
Brightspring Health Services
NASDAQ Global Select Market
FAQ
As of Today at 19:26 UTC, shares in Aveanna Healthcare Holdings are trading at $4.57. This share price information is delayed by 15 minutes.
Shares in Aveanna Healthcare Holdings last closed at $4.57 and the price had moved by +107.73% over the past 365 days. In terms of relative price strength the Aveanna Healthcare Holdings share price has outperformed the S&P500 Index by +91.74% over the past year.
The overall consensus recommendation for Aveanna Healthcare Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAveanna Healthcare Holdings does not currently pay a dividend.
Aveanna Healthcare Holdings does not currently pay a dividend.
Aveanna Healthcare Holdings does not currently pay a dividend.
To buy shares in Aveanna Healthcare Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.57, shares in Aveanna Healthcare Holdings had a market capitalisation of $891.58m.
Here are the trading details for Aveanna Healthcare Holdings:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: AVAH
Based on an overall assessment of its quality, value and momentum Aveanna Healthcare Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Aveanna Healthcare Holdings is $5.60. That is 22.54% above the last closing price of $4.57.
Analysts covering Aveanna Healthcare Holdings currently have a consensus Earnings Per Share (EPS) forecast of $0.12 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aveanna Healthcare Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -3.86%.
As of the last closing price of $4.57, shares in Aveanna Healthcare Holdings were trading -5.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aveanna Healthcare Holdings PE ratio based on its reported earnings over the past 12 months is 32.67. The shares last closed at $4.57.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aveanna Healthcare Holdings' management team is headed by:
- Rodney Windley - CHM
- Tony Strange - CEO
- David Afshar - CFO
- Jeff Shaner - COO
- Ed Reisz - CAD
- Patrick Cunningham - CCO
- Shannon Drake - GCN
- Beth Rubio - OTH
- Victor Ganzi - IND
- Chris Gordon - IND
- Devin Oreilly - IND
- Sheldon Retchin - IND
- Steven Rodgers - IND
- Robert Williams - IND
- Richard Zoretic - IND